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Background: Itch is one of the major somatosensory modalities. Some recent findings have proposed that gastrin
releasing peptide (Grp) is expressed in a subset of dorsal root ganglion (DRG) neurons and functions as a selective
neurotransmitter for transferring itch information to spinal cord interneurons. However, expression data from public
databases and earlier literatures indicate that Grp mRNA is only detected in dorsal spinal cord (dSC) whereas its
family member neuromedin B (Nmb) is highly expressed in DRG neurons. These contradictory results argue that a
thorough characterization of the expression of Grp and Nmb is warranted.
Findings: Grp mRNA is highly expressed in dSC but is barely detectable in DRGs of juvenile and adult mice.
Anti-bombesin serum specifically recognizes Grp but not Nmb. Grp is present in a small number of small-diameter
DRG neurons and in abundance in layers I and II of the spinal cord. The reduction of dSC Grp after dorsal root
rhizotomy is significantly different from those of DRG derived markers but similar to that of a spinal cord neuronal
marker. Double fluorescent in situ of Nmb and other molecular markers indicate that Nmb is highly and selectively
expressed in nociceptive and itch-sensitive DRG neurons.
Conclusion: The majority of dSC Grp is synthesized locally in dorsal spinal cord neurons. On the other hand, Nmb
is highly expressed in pain- and itch-sensing DRG neurons. Our findings provide direct anatomic evidence that Grp
could function locally in the dorsal spinal cord in addition to its roles in DRG neurons and that Nmb has potential
roles in nociceptive and itch-sensitive neurons. These results will improve our understanding about roles of Grp and
Nmb in mediating itch sensation.
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Itch is one of the major somatosensory modalities. Pruri-
togenic stimuli are detected by somatosensory neurons
in the dorsal root ganglia (DRG) and trigeminal ganglia,
which transmit itch information to the central nervous
system (CNS) by synapsing with dorsal spinal cord (dSC)
or medulla interneurons [1]. At present, neuronal
mechanisms mediating itch sensation are under intensive
investigation in order to identify novel targets for itch* Correspondence: louw@mail.med.upenn.edu
1Department of Neuroscience, Perelman School of Medicine, University of
Pennsylvania, 145 Johnson Pavilion, 3610 Hamilton Walk, Philadelphia,
PA19104, USA
Full list of author information is available at the end of the article
© 2012 Fleming et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortherapeutics. Some recent studies have proposed that
Grp selectively mediates the transmission of itch infor-
mation from the DRG to the dSC [2,3].
Grp belongs to the mammalian bombesin-like peptide
family, which contains two known members: Grp and
Nmb. Grp and Nmb share 80% and 70% identity with
bombesin, respectively [4], and selectively bind with high
affinity to their respective G-protein coupled receptors,
gastrin releasing peptide receptor (Grpr) and neuromedin
B receptor (Nmbr) [5] . Grp, Nmb and their receptors are
broadly expressed in mammals and their functions have
been implied in metabolic regulation, stress response, and
cancer pathogenesis [6-10]. Interestingly, both Grp andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[2,3,11].
The hypothesis that Grp functions as a selective neuro-
transmitter for itch sensation is supported by the com-
plementary expression pattern of Grp and Grpr in adult
mice, as Grp is detected in a subset of small diameter
DRG neurons and their nerve terminals innervating the
dSC, where Grpr is expressed. In addition, co-injection
of a Grpr antagonist with Grp negated the pruritogenic
effect of Grp. Furthermore, Grpr null mice or mice with
ablated bombesin-binding dSC neurons exhibited a spe-
cific reduced response to pruritogenic compounds [2,3].
Despite strong evidence in support of the function of
Grpr in mediating itch sensation, some concerns exist
about the expression pattern of Grp in DRG and dSC
neurons. First, in situ hybridization data from the Allen
Spinal Cord Atlas shows that Grp is highly expressed in
postnatal day 4 (P4) mouse dSC but it is barely detected
in DRG neurons [12]. In addition, the antibody used by
previous studies to detect Grp was a rabbit polyclonal
antibody generated against the bombesin peptide [2,3,13-
15]. Given the very high similarity between mouse Grp
and Nmb peptide sequences, it is conceivable that this
antibody may recognize both peptides. Indeed, Nmb is
highly expressed in DRG neurons [12]. Lastly, recent
physiological, pharmacological, and genetic studies have
demonstrated that glutamate functions as a neurotrans-
mitter of itch-sensing neurons to activate dSC neurons,
including Grp-responsive dSC neurons [13-16]. Thus, it is
necessary to thoroughly re-examine the expression of Grp
and Nmb in DRG and dSC to resolve some current
controversies.
In this study, we used a combination of approaches, in-
cluding in situ hybridization, reverse transcriptase PCR
(RT-PCR), real time PCR, immunohistochemistry, and
dorsal root rhizotomy to investigate the expression of
Grp and Nmb in DRG and dSC neurons. We found that
Nmb is highly expressed in DRG neurons and the ma-
jority of dSC Grp is synthesized locally in spinal cord
neurons. In addition, we found that Nmb is specifically
expressed in a subpopulation of nociceptive and itch
sensitive DRG neurons. Our results suggest that Grp
has additional local function in the dSC and Nmb may
have potential functions in itch- and pain-sensing DRG
neurons.
Results
Expression of GRP mRNA in juvenile and adult mouse
As mentioned above, Grp mRNA is found to be highly
expressed in P4 mouse dSC but it is barely detectable in
DRG neurons using in situ hybridization. On the other
hand, Grp has been shown to be specifically expressed in
a small population of adult itch-sensing mouse DRG
neurons using immunohistochemistry, and dSC Grp issuggested to be transported from DRG neurons [2]. At
least two possibilities can explain these inconsistent
results: one is that they reflect the normal dynamic ex-
pression pattern of Grp from early postnatal days to
adulthood, and the other is that Grp is expressed at a low
level in DRG neurons and these results reflect the sensi-
tivity or detection threshold of different techniques.
To address these two different possibilities, we first
characterized the expression pattern of Grp mRNA in ju-
venile and adult mice using in situ hybridization, RT-
PCR, and real time PCR. In addition, we investigated the
expression pattern of Grpr, the receptor for Grp, and the
other mammalian bombesin-related peptide, Nmb, and
its receptor, Nmbr. We performed in situ hybridization
for Grp, Grpr, Nmb, and Nmbr on juvenile (P14-P21)
wild-type DRG and dSC tissue (n = 3 mice). In agree-
ment with the Allen Spinal Cord Atlas P4 expression
data, we found that Grp and Grpr mRNA could be
detected in superficial layers of juvenile mouse dSC,
but not in DRG neurons (Figure 1A-1D). In contrast,
Nmb is highly expressed in ~50% of DRG neurons,
but not in dSC (Figure 1E-1F). We could not detect
the expression of Nmbr in either DRG or dSC at this
age, even with very high concentration of antisense
probe (Figure 1G-1H). This result is different from the
Allen Spinal Cord Atlas P4 data, which shows some
expression of Nmbr in superficial layers of the dSC.
This difference could be due to the dynamic expres-
sion of Nmbr as mice mature.
To examine the expression pattern of these transcripts
by a more sensitive approach, we performed RT-PCR on
RNA acutely isolated from either DRGs or dSC of adult
wild-type mice (n = 4 mice). In agreement with our in
situ hybridization data from juvenile mice, we found that
Grp and Grpr could be readily amplified from adult dSC
cDNA whereas Nmb was robustly amplified from adult
DRG cDNA (Figure 1I). Notably, a faint Grp band was
detected in DRG samples in four out of seven trials. This
band was consistently much fainter than the Grp product
amplified from dSC. As an amplification control, a ubi-
quitously expressed gene, Gapdh, was detected at similar
levels in DRG and dSC. The fact that Grp cDNA cannot
be consistently amplified from freshly isolated adult DRG
transcripts indicates that Grp is present in DRG neurons
at a very low level. This notion is also supported by evi-
dence that Grp could not be amplified from a commer-
cially prepared adult DRG cDNA library using PCR,
although Nmb was readily amplified from the same li-
brary (data not shown). To further quantify the relative
abundance of Grp mRNA in dSC and DRG, we per-
formed real time PCR with dSC and DRG cDNA. We
found that Grp transcript was present at a much higher
concentration in dSC relative to DRG (range = 63-1155
fold difference, n = 3 mice, 4 trials per sample)
Figure 1 Expression of Grp, Grpr, Nmb, and Nmbr mRNA in dSC and DRG neurons. (A-H) in situ hybridization with P21 wild type mouse
dSC and DRG for Grp (A-B), Grpr (C-D), Nmb (E-F), and Nmbr (G-H). dSC and DRGs are outlined with black dots. Scale bars = 50 μm. (I) RT-PCR
performed on RNA acutely isolated from wild type adult mouse dSC and DRG. cDNA was amplified with primers specific for Nmb, Grp, Nmbr, and
Grpr. Lower bands are cDNA amplified with primers specific for Gapdh, which served as a loading control. (J) Graphical representation of real time
RT-PCR for Grp performed on dSC and DRG RNA isolated from adult mice (n = 3 animals, 4 replicates per animal). Quantification represents fold
difference between dSC Grp relative to that of DRG. Relative abundance of cDNA was calculated in comparison to Gapdh housekeeping gene by
the 2^(−ΔΔCт) method (see details in method).
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Nmbr bands were amplified from dSC cDNA (Figure 1I).
These slightly different results obtained using in situ
hybridization and RT-PCR can be explained by the fact
that in situ hybridization is usually less sensitive com-
pared to reverse transcriptase-and real time PCR. Taken
together, our results reveal that Grp and Grpr mRNA are
highly expressed in dSC in both juvenile and adult mice
whereas Nmb mRNA is highly expressed in DRG neu-
rons. Additionally, Grp mRNA is expressed in juvenile
and adult mouse DRG neurons at a very low level, which
is near the detection threshold of RT-PCR but below that
of in-situ hybridization.
Characterization of the specificity of
anti-bombesin antiserum
The bombesin family of peptides contains two known
family members in mouse: Grp and Nmb. These peptides
share 80% and 70% identity, respectively, with the origin-
ally characterized member of this family, Bombina bom-
bina bombesin (Figure 2A). Previous studies [2,3,13-15]
have used a rabbit polyclonal anti-bombesin serum
(Immunostar, 20073) to detect the presence of Grp.
However, it has not been formally determined whether
this anti-bombesin serum selectively recognizes Grp. It is
conceivable that this polyclonal antibody detects both
Grp and Nmb, given the high similarity among bombe-
sin, Grp, and Nmb. To address this issue, we firstcharacterized the specificity of this polyclonal antibody
in vitro. In HEK293T cells, we expressed EGFP or EGFP
with C terminal fusion of bombesin, Grp, or Nmb. We
found that cells expressing EGFP-bombesin and EGFP-
Grp were stained by the anti-bombesin antiserum,
whereas cells expressing EGFP-Nmb or EGFP alone were
not recognized by the antiserum (Figure 2B-2M). These
findings indicate that the polyclonal antibody used in this
and previous studies selectively recognizes Grp but not
Nmb, which is quite surprising given the high level of
identity between these peptides and the immunizing
antigen.
Characterizing the expression of GRP in DRG neurons
and dSC using immunostaining
After establishing that the anti-bombesin antiserum se-
lectively recognizes Grp in vitro, we next examined the
staining pattern of the antiserum in vivo. In wild-type
P14-P21 mice, we observed that a small number of
small-diameter DRG neurons are immunopositive for the
anti-bombesin serum (1.79 ± 0.04% of lumbar DRG neu-
rons, n = 3 mice) (Figure 3A-3J). Consistent with previ-
ously published results, these Grp+ neurons are a
subpopulation of peptidergic nociceptors, as they are also
Cgrp+ (marker of peptidergic nociceptive DRG neurons),
but Pap-, IB4- (markers of nonpeptidergic nociceptors),
and VGlut1- (marker for mechanoreceptors and proprio-
ceptors). This small number of immunopositive neurons
Figure 2 In vitro characterization of anti-bombesin antiserum specificity. (A) Alignment of Bombina bombina bombesin, Mus musculus Grp,
and Mus musculus Nmb peptide sequences. Black bar underneath the bombesin peptide sequence indicates the immunizing peptide used for
developing the rabbit anti-bombesin antiserum. Grp and Nmb residues that share identity with the immunizing peptide are highlighted in red.
(B-M) HEK293 cells were transfected with EGFP-bombesin (B-D), EGFP-Grp (E-G), EGFP-Nmb (H-J), or EGFP alone (K-M) and immunostained with
anti-bombesin antiserum (red) and anti-GFP antibody (green). Scale bar = 25 μm.
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expressed at a very low level in juvenile mouse DRG
neurons.
In contrast to DRG neurons, we readily detected the
abundant presence of Grp in superficial layers of the dor-
sal spinal cord. Notably, the immunostaining signal of
Grp in dSC is much stronger than that of DRG neurons.
We found that Grp is mainly present in layer I and the
outer layer of layer II (IIo) of the spinal cord, as the in-
tense Grp signal overlaps with layers innervated by Cgrp,
a marker of peptidergic nociceptive DRG afferents termin-
ating in laminae I-IIo of the dorsal horn (Figure 3K-3L).
Some less intense Grp signal also overlaps with markers of
nonpeptidergic nociceptors, such as Pap and IB4, which
terminate in lamina IIi of the dorsal horn, and Pkcγ, which
is expressed in spinal cord neurons located in lamina
IIi and IIIo (Figures 3O-3R and 4A-4C) [17-19].
However, Grp immunostaining signal does not over-
lap with VGlut1+ puncta, which are formed by Aβmechanoreceptors innervating layers III-V (Figure 3S-3T)
[20]. High magnification images of dSC Grp staining show
that discrete Grp+ puncta are present around NeuN+ dSC
nuclei, indicating that Grp is expressed in dSC neurons
(Figure 3U). Taken together, our results reveal that Grp is
present at a high level in spinal cord superficial layer
neurons.
To further confirm the specificity of immunoreactivity
in dSC and DRG, we preabsorbed anti-bombesin anti-
serum with either bombesin or Grp peptide, and used
the supernatant to stain wild type mouse DRGs and
spinal cord (n = 3). We found a loss of Grp immunostain-
ing in both dSC and DRG after preabsorbing the anti-
serum, suggesting that the immunoreactivity we detected
in these regions was not due to nonspecific antibodies in
the antiserum (Figure 3C-3D and 3M-3N). Unfortu-
nately, the Grp null mouse, which would definitively ad-
dress the in vivo specificity of this anti-bombesin serum,
is not currently available to us.
Figure 3 Characterizing the localization of Grp in DRG, spinal cord, and dorsal root using anti-bombesin antiserum. (A-B) DRGs
immunostained with antibodies against bombesin (red) and Cgrp (green). Arrow indicates a bombesin+;Cgrp+ neuron. (C-D) DRG neurons in
adjacent sections are immunostained with anti-bombesin antiserum preabsorbed with purified Grp (red) and anti-Cgrp antibody (green).
Preabsorption results in a complete loss of anti-bombesin immunoreactivity. (E-F) DRG neurons immunostained with antibodies against
bombesin (red) and Pap (green). (G-H) DRG neurons immunostained with anti-bombesin anti-serum (red) and fluorescently-conjugated IB4
(green). (I-J) DRG neurons immunostained with antibodies against bombesin (red) and VGlut1 (green). Arrows in (E-J) indicate bombesin+
neurons that are not immunopositive for the costaining marker. (K-L) dSC section immunostained with antibodies against bombesin (red) and
Cgrp (green). The dSC layers positive for bombesin are outlined with white dots and higher magnification of the staining is shown in the inset.
(M-N) dSC section immunostained with anti-bombesin antiserum preabsorbed with purified Grp (red) and anti-Cgrp antibody (green), showing a
complete loss of anti-bombesin immunoreactivity. (O-P) dSC section immunostained with antibodies against bombesin (red) and Pap (green).
(Q-R) dSC section immunostained with anti-bombesin serum (red) and fluorescently-conjugated IB4 (green). (S-T) dSC section immunostained with
antibodies against bombesin (red) and VGlut1 (green). (U) A high magnification confocal image of adult dSC immunostained with anti-bombesin (red)
and anti-NeuN (green). (V-X) A higher magnification of wild type adult dorsal root immunostained with antibodies against bombesin (red) and Cgrp
(green) reveals the presence of Cgrp, but not Grp, in axons projecting from the DRG to dSC. Dorsal root is outlined by dotted line. Arrow indicates the
dSC anti-bombesin immunoreactivity. Scale bars = 50 μm (A-J), 100 μm (K-T), 5 μm (U), 30 μm (V-X).
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Even though Grp is present at a high level in layers I and
II of the spinal cord, its source is still unclear. It could be
synthesized locally in dorsal spinal cord neurons, as sug-
gested by the Grp mRNA expression pattern observed in
the Allen Spinal Cord Atlas and our own results, or it
could be synthesized in and transported from DRGneurons, as previously proposed [2]. Interestingly, Grp is
barely detected in dorsal root axons with this anti-
bombesin serum (Figure 3V-3X). In contrast, we found
that Cgrp, Pap, and IB4, which are known markers car-
ried by nociceptive afferents, intensely stain dorsal root
axons (Figure 3U-3W and data not shown). These find-
ings suggest that the amount of GRP transported from
Figure 4 Dorsal root rhizotomy causes a dramatic loss of Pap and Cgrp but significantly smaller changes of bombesin and Pkcγ in
dSC. L4, L5, and L6 central roots of two month old wild type mice were transected, and mice were examined two weeks following surgery.
Sections of the lumbar enlargement were immunostained to examine the loss of proteins and peptides caused by dorsal root axonal
degeneration and the contralateral side of the same spinal cord section was used as the control. (A-F) Sections were immunostained with
antibodies against bombesin (red) and Pkcγ (green), a protein highly synthesized in dSC neurons (control side (A-C) and transected side (D-F)).
Comparable and modest loss of both bombesin and Pkcγ immunoreactivity are found after the dorsal root rhizotomy. Enhanced green
fluorescence and abnormal morphology of the transected dorsal root were also noted, which may be caused by axonal inflammation after injury.
(G-L) Sections immunostained with antibodies against bombesin (red) and Pap (green). As noted, dSC Pap is dramatically decreased after the
dorsal root rhizotomy. (M-R) Sections immunostained with antibodies against bombesin (red) and Cgrp (green), another marker derived from
DRG neurons. Similar to Pap, dSC Cgrp is also greatly reduced following the dorsal root rhizotomy. Scale bar = 100 μm. (S) Quantification and
statistical analysis of dynamic changes of dSC Grp, Pkcγ, Pap, and Cgrp following the dorsal root rhizotomy. The loss of dSC Grp after dorsal root
rhizotomy is significantly different from those of Pap and Cgrp (P< 0.01), and the same is true for dSC Pkcγ. In contrast, no significant differences
are found between Grp and Pkcγ (P = 0.44) or Pap and Cgrp (P = 0.25).
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threshold of our method. So far, our data support that
most dSC Grp is synthesized in dSC neurons because:
1) abundant Grp transcript is detected in dSC using in-
situ hybridization and RT-PCR; 2) consistent with the
mRNA distribution, a high level of Grp is detected in
dSC by immunostaining; 3) a very low level of Grp tran-
script is detected in DRG neurons; 4) a small number of
Grp+ neurons are present in DRGs; and 5) Grp is barely
detected in dorsal root axons.
To further determine the source of dSC Grp, we per-
formed immunostaining on spinal cord following a uni-
lateral dorsal rhizotomy of L4/L5/L6 dorsal roots of adult
mice (n = 3). If the primary source of dSC Grp is due to
its synthesis in and release from somatosensory afferents,
we predict that immunostaining signal for dSC Grp
would be greatly decreased following the dorsal rhizot-
omy. However, if the primary source of dSC Grp is spinal
cord neurons, the change in immunostaining signal for
dSC Grp following dorsal root rhizotomy should not be
as dramatic. We sacrificed the animals two weeks after
rhizotomy to ensure that robust degeneration of dorsalroot axons had occurred. Spinal cord sections were
immunostained with anti-bombesin serum and other
antibodies marking DRG sensory axons or spinal cord
neurons. The change in immunofluorescence intensity
on the transected side was normalized to that of the con-
trol side (See methods for details). We found that follow-
ing L4/L5/L6 dorsal root transection, the intensity of
bombesin immunoreactivity is decreased (58.52 ± 8.00%
fluorescent intensity, transected/control). Importantly,
this decrease is not significantly different from the
change of immunoreactivity of Pkcγ (65.91 ± 12.78%
fluorescent intensity transected/control), a protein
known to be highly expressed in dorsal spinal cord neu-
rons (P = 0.44). The modest reduction of dSC Pkcγ and
Grp could be due to the loss of DRG neuron derived
Pkcγ and Grp and the denervation response of dSC neu-
rons [21,22]. On the other hand, the immunofluores-
cence intensity of dSC Pap (24.95 ± 5.58% fluorescent
intensity transected/control) and Cgrp (18.25 ± 7.84%
fluorescent intensity transected/control), markers pri-
marily transported from nonpeptidergic and peptidergic
nociceptors, were dramatically reduced (Figure 4A-4S).
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nificantly different from that of Cgrp and Pap (P< 0.01).
Taking all findings together, we conclude that the majority
of dSC Grp is synthesized locally.
Nmb is mainly expressed in small-diameter DRG neurons
Though Grp is only expressed in a few DRG neurons, the
other mammalian bombesin-like peptide, Nmb, is highly
expressed (Figure 1F). This specific expression pattern
suggests that Nmb may play a role in somatosensation.
Indeed, administration of Nmb has been shown to induce
scratching behavior, which can be blocked by administra-
tion of an Nmbr antagonist [11]. To further determine a
role for Nmb in the itch pathway or other somatosensory
modalities, it is important to characterize which subpo-
pulation of DRG neurons expresses Nmb. Since there is
no commercially available antibody that can reliably and
specifically detect Nmb (assay with EGFP-Nmb fusion
protein in HEK293 cells, data not shown), we performed
double fluorescent in situ hybridization (FISH) and FISHFigure 5 Nmb is expressed in small and large diameter DRG neurons.
an intermediate filament that is present in small diameter DRG neurons. Hi
peripherin (red bar) and the percentage of Peripherin+ neurons that expres
immunostaining for NF200 (green), a marker of large diameter myelinated
bar = 50 μm (I) Distribution of soma sizes of Nmb+, Peripherin+, and NF200combined with immunohistochemistry to establish the
molecular profile of Nmb+ DRG neurons in P21 mice.
We first examined whether Nmb is expressed in large-
or small-diameter DRG neurons. DRG neurons with dif-
ferent soma sizes have different developmental origins,
molecular profiles, physiological properties, and functional
modalities. Small-diameter, unmyelinated or thinly-
myelinated DRG neurons, which express the intermediate
filament peripherin, are mostly nociceptors. On the other
hand, medium- to large-diameter, highly-myelinated DRG
neurons, which express the intermediate filament neurofi-
lament heavy chain (Nfh), are mostly mechanoreceptors
and proprioceptors. To characterize the size distribution
of Nmb+ neurons, we performed FISH for Nmb and
combined it with immunostaining for either peripherin
or Nfh. We found that most Nmb+ neurons are small-
diameter DRG neurons as they are also peripherin+
(76.89 ± 6.62% Nmb+ neurons express peripherin;
51.53 ± 4.59% peripherin+ neurons express Nmb;
Figure 5A-5D). In addition, about a quarter of Nmb+(A-D) FISH for Nmb (red) and immunostaining for peripherin (green),
stogram shows the percentage of Nmb+ neurons that express
s Nmb (green bar). Mean± SEM. (E-H) FISH for Nmb (red) and
neurons, and quantification of overlapping expression. Scale
+ DRG neurons, in 100 μm2 bins.
Fleming et al. Molecular Pain 2012, 8:52 Page 8 of 17
http://www.molecularpain.com/content/8/1/52neurons are large-diameter and Nfh+ (28.53 ± 3.23%
Nmb+ neurons express Nfh; 28.73 ± 7.42% Nfh+ neurons
express Nmb; Figure 5E-5H). Furthermore, we mea-
sured the size of Nmb+ DRG neurons and plotted their
size distribution with regard to those of peripherin+ and
Nfh+ neurons. Our data illustrates a skewed distribution
in the size of Nmb+ neurons, with a majority of neurons
showing a size distribution similar to peripherin+ neu-
rons and a small proportion having larger areas compar-
able to Nfh+ neurons (Figure 5I). These results suggest
that Nmb is expressed in both small and large diameter
DRG neurons, but most Nmb+ neurons have small-
diameter somata.
Nmb is expressed in both peptidergic and
non-peptidergic nociceptors
As mentioned above, most small diameter DRG neurons
are nociceptors. To address whether Nmb is expressed in
pain- and itch-sensing DRG neurons, we first examined
Nmb expression in two broadly defined classes of pain-
sensitive neurons: peptidergic and nonpeptidergic noci-
ceptors. During embryonic development, all nociceptors
express TrkA, the neurotrophic receptor tyrosine kinase
for nerve growth factor (NGF). In the first two postnatal
weeks, however, DRG neurons that differentiate into
nonpeptidergic nociceptors extinguish their expression
of TrkA and express another receptor tyrosine kinase,
Ret, while peptidergic nociceptors retain their expression
of TrkA into adulthood [17,23]. We performed double
FISH for Nmb and Ret or TrkA to determine which
classes of nociceptors express Nmb. Almost all TrkA+
neurons (41.99 ± 2.01% of Nmb+ neurons express TrkA;
94.59 ± 1.14% of TrkA+ neurons express Nmb) and ma-
jority of Ret+ neurons (72.14 ± 2.54% of Nmb+ neurons
express Ret; 75.04 ± 1.58% of Ret+ neurons express Nmb)
express Nmb (Figure 6A-H). The Ret+ DRG neurons are
comprised of both small-diameter nonpeptidergic noci-
ceptors and larger-diameter rapidly adapting (RA)
mechanoreceptors [24]. Interestingly, all large-diameter
Ret+ RA mechanoreceptors are Nmb- (arrow, Figure 6B-
6C), and the proportion of Ret+ neurons that co-express
Nmb is very similar to the proportion of Ret+ DRG neu-
rons that are nociceptors [17,25]. Additionally, we found
that almost all Nmb+ neurons express either Ret or TrkA
(98.78 ± 0.12% of total NMB+ neurons) when we combine
double FISH for Nmb and Ret with immunohistochemis-
try for TrkA (Figure 6I-6M). We also note that Nmb+/TrkA+
neurons are larger than Nmb+/Ret+ neurons. In short,
these results indicate that Nmb is specifically expressed in
both peptidergic and non-peptidergic nociceptors.
To further confirm the expression of Nmb in nonpepti-
dergic nociceptors we combined Nmb FISH with immu-
nostaining for Pap or binding of isolectin-B4, markers
that exclusively label nonpeptidergic nociceptors. Nmbwas expressed in nearly all DRG neurons that bind IB4
(49.20 ± 2.98% of Nmb+ neurons bind IB4; 98.47 ± 0.25%
of IB4-binding neurons express Nmb) or that are Pap+
(72.61± 2.79% of Nmb+ neurons express Pap;
97.28±0.23% of Pap+ neurons express Nmb) (Figure 6N-
6U). Additionally, we examined the expression of Nmb in
neurons that express the G-protein coupled receptor
MrgprD, which comprise a large subset of nonpeptidergic
nociceptors which mediate the sensation of mechanical
pain [26]. Nmb was expressed in all DRG neurons which
express MrgprD (49.89±1.24% of Nmb+ neurons express
MrgprD; 100± 0% of MrgprD+ neurons express Nmb)
(Figure 6V-6Y). Taken together, our data indicate that
Nmb is expressed in nearly all peptidergic and nonpepti-
dergic nociceptors.
Nmb is expressed in itch-sensing neurons
Itch-sensing neurons have been suggested to be a subpo-
pulation of nociceptors. We next asked whether Nmb is
present in potential itch-sensing DRG neurons. The tran-
sient receptor potential channel TrpV1 was originally
characterized as the channel mediating the burning sen-
sation associated with capsaicin administration [27].
Additionally, TrpV1+ neurons have been shown to play
important roles in the detection of noxious heat and
mediation of itch sensation in response to histaminergic
stimuli [28,29]. Double FISH revealed that Nmb is
expressed in approximately half of TrpV1+ DRG neu-
rons (20.94 ± 0.56% of Nmb+ neurons express TrpV1;
53.72 ± 3.66% of TrpV1+ neurons express Nmb)
(Figure 7A-D).
To further investigate the expression of Nmb in itch-
sensing DRG neurons, we performed double FISH for
Nmb and MrgprA3. MrgprA3 is a G-protein coupled re-
ceptor which is expressed in a subset of small diameter
DRG neurons and is activated by chloroquine, a non-
histaminergic pruritogen [30]. Remarkably, we found that
almost all MrgprA3+ DRG neurons co-express Nmb,
even though MrgprA3 is expressed in only a small pro-
portion of Nmb+ neurons(15.10 ± 0.93% Nmb+ neurons
express MrgprA3; 99.19 ± 0.81% MrgprA3+ neurons ex-
press Nmb) (Figure 7E-H). In summary, our results sug-
gest that Nmb is expressed in populations of DRG
neurons that mediate itch sensation.
Nmb is not expressed in cold-sensing and low-threshold
mechanosensory neurons
Subsets of small-diameter DRG neurons have been
shown to respond optimally to various stimuli, including
pruritogens, noxious thermal, mechanical, or chemical
stimuli, innocuous temperature, or light touch. To test if
the expression of Nmb is specific to pain- and itch-
sensing neurons, we also performed double FISH for
Nmb and molecular markers that identify temperature-
Figure 6 Nmb is expressed in peptidergic and nonpeptidergic nociceptors. (A-D) FISH for Nmb (red) and Ret (green), a marker for small
diameter nonpeptidergic nociceptors and RA mechanoreceptors. Arrow indicates a large diameter, Ret+ neuron, all of which are Nmb-. (E-H) FISH
for Nmb (red) and TrkA (green), a marker for peptidergic nociceptors. (I-M) FISH for Nmb (red) and Ret (green), combined with immunostaining
for TrkA (blue). Quantification shows the percentages of Nmb+ neurons which also express Ret or TrkA (green), or which express neither marker
(red). (N-Q) FISH for Nmb (red) and binding of IB4 (green). (R-U) FISH for Nmb (red) combined with immunostaining for Pap (green). (V-Y) FISH
for Nmb (red) and MrgprD (green). Scale bar = 50 μm.
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transient receptor potential channel, TrpM8. TrpM8 has
been shown to be important for the detection of environ-
mental, but not noxious, cold (temperatures ~15°-26°C),and to be activated by chemicals which induce a cooling
sensation, such as methanol and icilin [31]. Interestingly,
expression of Nmb is almost completely non-overlapping
with that of TrpM8 (0.08 ± 0.08% Nmb+ neurons express
Figure 7 Nmb is expressed in itch-sensitive DRG neurons. (A-D) FISH for Nmb (red) and TrpV1 (green), a marker of neurons responding to
noxious and histaminergic itch stimuli. (E-H) FISH for Nmb (red) and MrgprA3 (green), a marker of neurons responding to nonhistaminergic itch.
Scale bar = 50 μm.
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(Figure 8A-D).
To further test our hypothesis that Nmb is specifically
expressed in pain- and itch- sensing neurons, we com-
pared the expression of Nmb to markers of low-
threshold mechanosensitive neurons, which mediate the
sensation of light touch, texture, form, vibration, and
body position. Low-threshold mechanosensory neurons
contain several different groups of DRG neurons, each of
which have distinct molecular and developmental pro-
files. We examined the expression of Nmb with regard to
three classes of low-threshold mechanosensitive neurons:
Aδ low-threshold mechanoreceptors (Aδ LTMRs), c-
fiber low-threshold mechanoreceptors (C-LTMRs), and
proprioceptors.
Aδ LTMRs, which are also known as D-hair, express
the neurotrophic tyrosine kinase receptor TrkB postna-
tally [32]. We found that the expression of TrkB and
Nmb mRNA is completely non-overlapping in juvenile
mouse DRG neurons (0 ± 0% Nmb+ neurons express
TrkB; 0 ± 0% TrkB+ neurons express Nmb) (Figure 8E-
8H). We also examined the overlap between Nmb and
tyrosine hydroxylase (Th), a marker that is expressed
postnatally in intermediately adapting, small-diameter C
fiber LTMRs [32]. Even though most Nmb+ neurons have
small-diameter somata, we found minimal overlap be-
tween Nmb and Th expression (0.37 ± 0.26% Nmb+ neu-
rons express Th; 1.64 ± 1.09% Th+ neurons express Nmb)
(Figure 8I-8L). Moreover, we have shown in the previous
section that Nmb is not expressed in large-diameter Ret+
neurons, which are Aβ RA mechanoreceptors
(Figure 6C). Taken together, our results strongly suggest
that Nmb is not expressed in LTMRs, which is consistentwith our hypothesis that Nmb is expressed exclusively in
pain- and itch- sensing neurons.
We next examined the expression of Nmb in neurons
which express the neurotrophic receptor tyrosine kinase
TrkC, which is commonly used as a marker of proprio-
ceptive and Aβ slowly adapting mechanosensitive DRG
neurons. We found that a very small percentage of Nmb+
neurons co-express TrkC (4.81 ± 0.93% Nmb+ neurons
express TrkC; 22.86 ± 1.16% TrkC+ neurons express
Nmb) (Figure 8M-8P). Attempts to further clarify
whether Nmb is expressed in proprioceptors were unsuc-
cessful, as another classical immunohistochemical mar-
ker of proprioceptors, parvalbumin, did not work in
combination with our in-situ hybridization protocol. At
present, we are uncertain about the functional identity of
these Nmb+/TrkC+ neurons. Nevertheless, our hypothesis
that Nmb is specifically expressed in pain- and itch-
sensing neurons should still be true, as Nmb+/TrkC+
neurons are only a very small percentage of total Nmb+
neurons (less than 5%).Discussion
In this paper, we have presented evidence demonstrating
that Grp, which has been proposed to act as a selective
neurotransmitter of itching sensation from the DRG to the
dSC, is also highly expressed in dSC neurons. In addition,
we have found that Nmb, a homologue of Grp, is highly
and selectively expressed in pain- and itch-sensing DRG
neurons. Our anatomical characterization suggests that
Grp can function intraspinally in dSC neurons in addition
to its potential roles in DRG neurons and Nmb could play
roles in pain- and itch-sensing neurons.
Figure 8 Nmb is not expressed in DRG neurons responding to innocuous thermal or mechanical stimuli. (A-D) FISH for Nmb (red) and
TrpM8 (green), a marker of neurons responding to innocuous cold stimuli. (E-H) FISH for Nmb (red) and TrkB (green), a marker of Aδ LTMRs. (I-L)
FISH for Nmb (red) and TH (green), a marker of a population of intermediately adapting C fiber LTMRs. (M-P) FISH for Nmb (red) and TrkC (green),
a marker of slowly adapting mechanoreceptors and proprioceptors. Scale bar = 50 μm.
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By employing multiple methods to detect Grp mRNA
and protein, we found that Grp is robustly expressed in
dSC neurons. Even though a previous publication sug-
gests that no Grp mRNA is detected in adult mouse
spinal cord by in situ hybridization [2], we detected
abundant Grp mRNA in both juvenile and adult mouse
dorsal spinal cord using in situ hybridization, RT-PCR,
and real time PCR. We cannot make a comparison or
suggest possible explanations for these different results
because the in situ hybridization data of Grp in the previ-
ous publication is not shown. Nevertheless, our results
are in line with the P4 in situ hybridization data of the
Allen Mouse Spinal Cord Atlas, suggesting that the ex-
pression pattern of Grp in DRG and SC neurons is fairly
stable from early postnatal days to adulthood [12]. Our
results are also consistent with the P7 and adult Grp ex-
pression pattern provided by the St. Jude Brain Gene Ex-
pression Map (BGEM) using a radioactive in situhybridization method [33]. Furthermore, Grp mRNA was
shown to be highly expressed in dSC in adult rat [6].
Taken together, our results and information from public
databases strongly support the conclusion that Grp
mRNA is highly expressed in postnatal dSC neurons.
In agreement with the low level of Grp mRNA found
in DRG neurons (Figure 1B and references [6,12] ), we
only detected a small number of Grp+ DRG neurons
using immunostaining (Figure 3A-3G). The Grp+ neu-
rons we detected are much less than that found in a pre-
vious publication (8.6% of lumbar DRG neurons [2]).
This difference could be due to different fixation condi-
tions. Though we detected a robust level of Grp peptide
in dSC neurons using immunostaining (Figure 3K, O, Q,
S), we barely detect any Grp in dorsal root nerve
(Figure 3V), the only pathway between DRG neurons
and dSC, indicating that the amount of Grp synthesized
and transported from DRG to dSC is minimal and below
the detection level of our methods.
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conducted the dorsal root rhizotomy. Since proteins or
peptides derived from DRG neurons need to be trans-
ported through the dorsal root, their presence in the
spinal cord should dramatically decrease following cen-
tral root rhizotomy. On the other hand, reduction of pro-
teins or peptides that are primarily synthesized in dSC
neurons should not be as dramatic. Indeed, we found
~80% decrease of markers originating from DRG neu-
rons, such as Cgrp and Pap, and only found ~ 35% de-
crease of a spinal neuron marker, Pkcγ. Importantly, the
change of dSC Grp is significantly different from DRG
neuron derived markers but similar to that of Pkcγ
(Figure 4S), suggesting that the majority of Grp is synthe-
sized locally in dSC neurons. This result is consistent
with the expression pattern of Grp mRNA. Taking all
data into consideration, our results strongly argue that a
majority of dSC Grp is synthesized locally in spinal cord
neurons.
Nmb is specifically expressed in pain- and itch-sensing
DRG neurons
In contrast to Grp, we found that the other known mam-
malian bombesin peptide, Nmb, is highly expressed in
DRG neurons. By co-staining with molecular markers for
different modalities of somatosensory neurons, we found
that Nmb is selectively expressed in pain- and itch-
sensing neurons. This specific expression pattern sug-
gests that Nmb may play a role in these neurons. In
addition to its potential role as a neurotransmitter in
pain- and itch-sensing neurons, as discussed below, an-
other interesting possibility is that DRG neuron derived
Nmb may be released by peripheral axons and functions
peripherally. In fact, we detected some expression of
Nmbr in mouse glabrous skin by in situ hybridization
(data not shown). Moreover, Nmbr mRNA levels were
found to be increased following mechanical wounding
and bombesin can promote keratinocyte mitosis and migra-
tion in vitro [34]. These observations and our anatomical
characterization raise the intriguing possibility that Nmb
could be released from free nerve terminals upon injury to
promote skin regeneration and wound healing.
Neurotransmitter for itch-sensing somatosensory neurons
Which chemical do itch-sensing somatosensory neurons
use as the pruritogenic neurotransmitter? This is an im-
portant question as a pruritogenic specific neurotrans-
mitter would be a potential target for treating patients
with pruritic disease. Some recent studies have proposed
glutamate and Grp as two candidate neurotransmitters
for itch-sensing somatosensory neurons [2,14-16]. One
anatomical requirement for a chemical to function as the
pruritogenic neurotransmitter is that it is synthesized in
DRG neurons, transported to dSC, and activates itsreceptor, which is expressed in postsynaptic neurons. We
found that Grp mRNA is expressed at a low level in DRG
neurons and a small amount of Grp is transported from
DRG neurons to dSC. Interestingly, we found that a high
level of Grp is synthesized in dSC neurons, which may
also contribute to normal itch perception by modulating
the spinal cord local circuits. Future molecular and be-
havior analysis with Grp null or DRG vs. dSC specific
Grp knockout mice will help to address the expression
and function of DRG neuron and dSC neuron derived
Grp.
On the other hand, Nmb, the other mammalian
bombesin-related peptide, could be an interesting candi-
date neurotransmitter to modulate pain and itch sensa-
tion, given its high and selective expression in DRG
neurons. Though we did not detect significant amount of
Nmbr mRNA in dSC using in situ hybridization at P21,
intrathecal injection of Nmb induces itching behavior
[11]. This response may be conducted through Nmbr,
which could be expressed in dSC at a low level. Alterna-
tively, Nmb could be acting though Grpr, which Nmb
can bind to with a low affinity [5]. Thus, a good antibody
against Nmbr or behavior analysis with Nmb and Nmbr
knockout mice in the future will help to address the
localization of Nmbr and physiological roles of DRG
neuron derived Nmb.
Conclusions
We have found that Grp transcript is highly expressed in
dSC neurons and the majority dSC Grp is synthesized lo-
cally. On the other hand, Grp transcript is expressed at a
low level in DRG neurons, and that the contribution of
DRG neuron-derived Grp to the total amount of Grp
observed in the dSC is relatively small. In addition, we
have shown that Nmb, the other mammalian bombesin-
related peptide, is highly expressed in pain- and itch-
sensing DRG neurons. Taken together, our results sug-
gest that intraspinally synthesized Grp may have a local
function in addition to potential functions of DRG
neuron-derived Grp and that Nmb may play a role in itch-
or pain-sensing neurons. This anatomical characterization
of Grp and Nmb will improve our understanding about
roles of Grp and Nmb in mediating itch sensation.
Materials and methods
Animals
Mice were raised in a barrier facility in the Hill Pavilion,
University of Pennsylvania. All animal procedures were
conducted according to animal protocols approved by
the Institutional Animal Care and Use Committee
(IACUC) of the University of Pennsylvania. For in-situ
hybridization and antibody characterization studies, six
P14-P21 wild type mice of both sexes with a mixed CD1/
C57Bl/6 J background were used. For RT-PCR
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sexes with a mixed CD1/C57Bl/6 J background were
used. For dorsal rhizotomy experiments, we used
2month old C57Bl/6 J mice of either sex and the survival
surgery was conducted in Shriners Hospitals Pediatric
Research Center, Temple University. All surgical and
postoperative procedures were performed in accordance
with Temple’s Institutional Animal Care and Use Com-
mittee and National Institutes of Health guidelines.
In situ hybridization
DIG-labeled riboprobes were synthesized using a DIG
RNA labeling kit (Roche, 11175025910). Template for
Nmb probe was amplified from a mouse DRG cDNA li-
brary (BD, Ref#630022) and subcloned into vector pGEM-
T Easy (Promega, A1360). Mouse IMAGE clones for Grp
(GenBank: BC024515), Grpr (GenBank: BC113145), and
Nmbr (GenBank: BC119237) were purchased from Open
Biosystems, and PCR products were subcloned into








probes for c-Ret, TrkB, TrkC, TrpV1, MrgprA3, MrgprD,
and TrpM8 were generated as previously described [23,35].
Intact lumbar spinal column was dissected from
euthanized wild-type P14-P21 mice and rapidly frozen in
OCT on a dry-ice/ethanol bath. 20 μm cryosections
were collected on Superfrost Plus slides (Fisher, 22-034-
979) and allowed to dry for at least 2 hours at room
temperature before in-situ hybridization. All steps prior
to hybridization were carried out under RNase free con-
ditions. Cryosections were immersion-fixed in freshly
made 4% PFA in PBS for 20 minutes at room
temperature. Slides were then washed in fresh-DEPC
PBS (1:1000 DEPC in PBS immediately before use), fol-
lowed by wash in DEPC-pretreated PBS (1:1000 DEPC
in PBS overnight (O/N), followed by autoclaving). An
antigen retrieval step, often used for immunohistochem-
istry, was found to increase the signal of many probes.
Citric acid buffer (10 mM citric acid, 0.05% Tween-20,
pH6.0) was boiled in a microwave, and DEPC (1:1000)
was added to freshly boiled solution. Slides were
immersed in solution in a 95°C waterbath for 20 min-
utes, and then allowed to cool at room temperature
for 30 minutes. Sections were then washed in DEPC
pretreated PBS (1X 5 minutes), incubated in Proteinase
K (25 μg/mL in DEPC-pretreated H2O) for five min-
utes, followed by washes in fresh-DEPC PBS (1X 5
minutes) and DEPC pre-treated PBS (1X 5 minutes).Sections were then acetylated at room temperature for
ten minutes in freshly made acetylation solution
(0.1 M triethanolamine, 0.25% acetic anhydride in
DEPC pre-treated H2O). Slides were then prehybri-
dized in hybridization buffer (50% formamide, 5XSSC,
0.3 mg/mL yeast tRNA, 100 μg/mL heparin, 1X Den-
hardt’s, 0.1% Tween-20, 0.1% CHAPS, 5 mM EDTA in
RNase free H2O) at 62°C in a humidified chamber for 30
minutes. Following prehybridization, excess hybridization
buffer was removed from slides and 1-2 ng/μl of DIG and/
or FITC labeled riboprobe diluted in hybridization buffer
was placed on the slide. Slides were incubated O/N under
Parafilm coverslips at 62°C. Slides were then washed in
0.2X SSC at 68°C (1X 15 minutes, 2X 30 minutes).
For colorimetric reaction, slides were blocked in PBT
(PBS, 0.1% TritonX-100) and 20% lamb serum at room
temperature for one hour. Sections were then incubated
with AP-conjugated anti-DIG antibody (1:1000; Roche,
11093274910) in blocking buffer O/N at 4°C. Slides were
washed in PBT (3X 10 minutes) and incubated O/N in
darkness in alkaline phosphatase buffer (100 mM Tris
pH9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-20,
5 mM levamisole, 0.34 mg/mL 4-Nitro blue tetrazolium
(NBT)(Roche, 11383213001), 0.17 mg/mL 5-bromo-4
-chloro-3-indolyl-phosphate(BCIP)(Roche, 1138221001)).
Following color reaction, slides were rinsed repeatedly in
PBS and then fixed for 20 minutes in 4% PFA in PBS at
room temperature. Slides were then repeatedly rinsed in
ddH2O, dried at 37°C for 1 hour, dehydrated in xylenes
(3X 2 minutes), and coverslipped with Permount (Fisher,
SP15).
For double fluorescent in-situ hybridization (FISH),
slides were blocked for one hour at room temperature
with 0.5% Blocking Reagent (Roche, 11096176001) in
PBS. Sections were incubated in anti-FITC-POD (1:100
in .5% Blocking Reagent; Roche, 11426346910) O/N at
4°C. Slides were then washed in PBT (3X10 minutes)
and incubated in 0.1% BSA in PBS for 15 minutes. FITC
riboprobes were then developed using the TSA Plus sys-
tem (Perkin Elmer, NEL741001KT), by diluting fluores-
cein tyramide into 1X amplification buffer (1:100) and
incubating slides in working solution for 10–15 minutes,
followed by washes in PBS (3X 10 minutes). Slides were
then blocked in PBT containing 20% lamb serum for 1
hour at room temperature, and incubated O/N at 4°C
with AP-conjugated anti-DIG antibody (1:500 in PBT
+20% lamb serum). Slides were washed in TNT
(100 mM Tris–HCl, 150 mM NaCl, 0.05% Tween-20,
pH7.5) (3X 10 minutes), then in detection buffer
(100 mM Tris–HCl, 100 mM NaCl, 10 mM MgCl2,
pH8.0) (2X 10 minutes). DIG-labeled riboprobes were
then developed using HNPP/Fast Red TR system (Roche,
11758888001). Sections were incubated in detection so-
lution (10μL HNPP stock solution, 10μL of 25 mg/mL
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0.2 μM nylon filter) (3x30 minutes), with TNT rinses
between incubations. Slides were then rinsed in PBS
and mounted with Flourmount (Southern Biotech,
0100–01).
For FISH combined with immunofluorescence, normal
hybridization procedure was followed, using DIG-labeled
probe. After 0.2X SSC washes, sections were blocked for
one hour in PBT containing 20% lamb serum. Sections
were then incubated with AP-conjugated anti-DIG
(1:500) and primary antibody at the appropriate dilution
(described below) at 4°C O/N in 20% lamb serum blocking
solution. Slides were washed in PBT (3X 10 minutes), then
incubated in species appropriate Alexa 488 conjugated
secondary antibody (1:500 in 5% lamb serum in PBT) for
one hour at RT. HNPP/FastRed detection was then per-
formed as described above, beginning with initial TNT
washes.Immunohistochemistry
For characterization of anti-bombesin antibody, P14-P21
mice were deeply anesthetized with CO2 and perfused
with 4% PFA in PBS. Intact lumbar spinal columns were
dissected and post-fixed for 2–4 hours in 4% PFA in PBS
at 4°C, cryoprotected in 30% sucrose in PBS O/N at 4°C,
and embedded in OCT. 20 μm cryosections of lumbar
spinal cord and DRG were collected on Superfrost Plus
slides, and allowed to dry at room temperature for at least
two hours. For dorsal rhizotomy samples, 30 μm free
floating cryosections were collected in PBT and processed
for immunohistochemistry in solution. Sections were
washed in PBT (3X 10 minutes), and then blocked in PBS
containing 5% lamb serum and 0.3% TritonX-100 for 1
hour at room temperature. Primary antibodies were
diluted in the same buffer, and incubated O/N at 4°C, then
washed in PBT (3X 10 minutes). Secondary antibodies
were incubated in blocking buffer at 1:1000 dilution for
one hour at room temperature. Slides were then washed
in PBT (3X 10 minutes) and mounted with Flourmount.
Primary antibodies used include rabbit anti-bombesin
(1:1000; ImmunoStar, 20073), chicken anti-Gfp (1:2000;
Aves, GFP-1020), guinea pig anti-Cgrp (1:250; Bachem,
T-5053), mouse anti-Pkcγ (1:50, Invitrogen, 13–3800),
chicken anti-Pap (1:1000; Aves, PAP), rabbit anti-
peripherin (1:1000; Millipore, AB1530), rabbit anti-Nfh
(1:2000; Sigma, N4142), rabbit anti-TrkA (1:1000; Milli-
pore, 06–574), rabbit anti-tyrosine hydroxylase (1:100;
Millipore, AB152), mouse anti-NeuN (1:1000, Millipore,
MAB377), and Alexa 488 conjugated IB4 (1:200; Invi-
trogen, I21411). Secondary antibodies used were Alexa
488, Alexa 594, or Alexa 647 conjugated goat anti-
rabbit antibody, Alexa 488 conjugated goat anti-mouse
antibody, Alexa 488 conjugated goat anti-chickenantibody, and Alexa 488 conjugated goat anti-guinea pig
antibody. All secondary antibodies were purchased from
Invitrogen.Peptide preabsorption
Anti-bombesin and anti-Cgrp antibodies at the concen-
trations described above were added to PBS containing
5% lamb serum, 0.3% TritonX-100, and bombesin pep-
tide (50 μg/mL; American Peptide Company, 16-7-10A)
or GRP peptide (50 μg/mL; American Peptide Company,
62-3-10) and incubated O/N at 4°C with gentle agitation.
Solutions were centrifuged at high speed (~16,000 x g)
for ten minutes, and supernatant was used for immuno-
histochemistry, as described above.Reverse transcriptase PCR
4–6 month old wild type mice were deeply anesthetized
with CO2, transcardially perfused with sterile, RNAse free,
ice-cold PBS, then decapitated. Lumbar and thoracic
DRGs and dorsal spinal cord were dissected under RNase
free conditions and rapidly frozen on dry ice. RNA was
isolated using the GeneJet RNA Purification Kit (Fermentas,
K0731), and cDNA was synthesized with oligo-dt primers
using the SuperScript First-Strand Synthesis system (Invi-
trogen, 11904018). PCR was performed on cDNA synthe-
sized from DRG or dorsal spinal cord cDNA with primers







3’), and Gapdh (5’-GGTGAAGGTCGGTGTGAACG-
3’ and 5’-CTCGCTCCTGGAAGATGGTG-3’).Real time PCR
Grp mRNA from DRG or dSC were measured by quanti-
tative real-time PCR under the ABI 7500 Fast Real-Time
PCR system (Applied Biosystems, Foster City, CA), with
Gapdh as an internal reference gene. The reaction mix-
ture contained 250 nM of each primer, 1 × SYBR Green
PCR Master Mix (ABI), and 1 μl of cDNA. Relative con-
centration of Grp present in each cDNA sample was cal-
culated by the comparative C(T) method [36]. Real time
PCR was performed on cDNA isolated from three adult
wild type mice, and was repeated four times per sample.
Primers used were Grp primers listed above, and Gapdh
(5’-TCGGTGTGAACGGATTTGGC-3’and 5’-TCCCAT
TCTCGGCTTGACT-3’).
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Plasmids were constructed to express bombesin, Grp, or
Nmb fused to the C terminus of EGFP. The coding
regions of the peptides were constructed by annealing
oligonucleotides coding for the open reading frame of
each peptide with EcoRI (5’) and SalI (3’) sticky ends.











tides were phosphorylated with T4 polynucleotide kinase
(PNK) (NEB, M0201) for 20 minutes at 37°C, and then
PNK was heat inactivated at 65°C for 20 minutes. Phos-
phorylated oligonucleotides were annealed by heating to
95°C for five minutes, then allowing them to cool to room
temperature. Annealed oligonucleotides were then ligated
into pPMS93 (a gift from Dr. Jeremy Nathans lab at Johns
Hopkins University, CMV promoter to drive the expres-
sion of EGFP C-terminal fusion protein) pre-digested with
EcoRI and SalI. Ligated plasmids were transformed into
DH5-α, and grown overnight at 37°C on agarose plates
supplemented with 100 μg/mL carbenicillin. Individual
colonies were then selected and grown overnight in 2XYT
containing 100 μg/mL carbenicillin, and then mini-
prepped (Fermentas, K0503). Correct insertions were con-
firmed by DNA sequencing.
Cell culture and immunocytochemistry
QBI HEK293 cells were grown on 12 mm circle cover-
slips in HEK293 growth media (10% FBS (Invitrogen,
10082147), 1% Penicillin/Streptomycin (Invitrogen,
15140122) in DMEM (Invitrogen, 11965084)) in 6-well
tissue culture plates. Coverslips were coated with
100 μg/mL poly-D-lysine solution to help cell adhesion.
Individual cultures were transfected with 1 μg/mL of
pRK5-EGFP, pPMS-bombesin, pPMS-Grp, or pPMS-
Nmb EGFP fusion plasmid with Lipofectamine LTX
(Invitrogen, 15338100). Eighteen to twenty four hours
after transfection, coverslips were then rinsed gently
with PBS and fixed in 4% PFA in PBS for 1.5 hours at
room temperature. Coverslips were then processed for
immunohistochemistry as described above.
Dorsal root rhizotomy and postoperative procedures
The surgical procedure was standard [37]. Mice were
anesthetized with an intraperitoneal injection of xylazine
(8 mg/kg) and ketamine (120 mg/kg). Supplements weregiven during the procedure as necessary. A 2- to 3-cm-
long incision was made in the skin of the back; the
spinal musculature was reflected; and the L5 spinal cord
segments were exposed by hemi-laminectomies. The
cavity made by the laminectomies was perfused with
warm sterile Ringer's solution. A small incision was
made in the dura overlying the L3-L5 dorsal roots; a fine
spring scissor (501778, World Precision Instruments)
was introduced subdurally and L4, L5, and L6 dorsal
roots were cut. The laminectomy site was covered with
a piece of thin synthetic matrix membrane (Biobrane,
Bertek Pharmaceuticals), which was then stabilized with
a layer of thicker artificial dura (Gore Preclude MVP
Dura Substitute, W.L. Gore and Associates). Animals are
given subcutaneous injections of lactated Ringer's solu-
tion to prevent dehydration and are kept on a heating
pad until fully recovered from anesthesia. Buprenex is
given as post-operative analgesia (0.05 mg/kg S.C. every
12 hours for 2 days). On the 15th day after dorsal rhizot-
omy, mice were perfused transcardially with 0.9% hepar-
inized saline solution followed by 4% paraformaldehyde
in PBS.
Imaging
All images were acquired on a Leica DM5000B or Leica
TCS SP5 II and processed using Adobe Photoshop CCS
version 12.0.
Quantification and statistics
For dorsal rhizotomy experiments, adjacent sections of
the spinal cord lumbar enlargement were used for differ-
ent marker staining. Images of each dorsal horn of indi-
vidual sections were acquired using identical exposure
conditions. Using ImageJ, the bombesin reactive and
Cgrp, Pkcγ, or Pap (costain) reactive regions of dorsal
spinal cord were outlined. Pixel counts for each fluores-
cence intensity value (0–255) within the outlined region
were generated by ImageJ. In addition, background pixel
intensity values were generated from a non-reactive area
of the dorsal spinal cord for each image. Background
pixel counts were clustered around low intensity values
and showed a normal distribution, and the threshold for
background fluorescence cutoff was established as the
first highest intensity value that had a pixel count of
zero. To calculate total fluorescence intensity, the pixel
count for each intensity above background level was
multiplied by its intensity, and the results of these calcu-
lations were summed. In cases where the immunostain-
ing signal was greatly reduced on transected side, the
stain area was approximated based on the control side.
The difference between the control and transected side
was calculated as percentage change in fluorescent in-
tensity ([fluorescent intensity transected/fluorescent in-
tensity control]*100). This value was calculated for three
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for each marker across all sections was calculated, and
P-values were calculated using a two-tailed student’s t-test.
Cell size calculations
ImageJ software was used to calculate size of DRG neu-
rons. All images were taken at 20x magnification. To
avoid bias in counting, the first 25 positive cells in each
image from left to right were counted. In total, 225 cells
per marker were counted (n = 3 animals, 9 DRG per ani-
mal). Using ImageJ, cells were outlined using the lasso
tool and the area was obtained. For graphical representa-
tion, cells were divided into 100um2 bins.
Expression profile quantification
Expression profile of Nmb+ DRG neurons was evaluated
by counting the number of cells that were positive for
Nmb, co-staining markers, or both in 3 wild-type P14-
P21 animals (6–8 lumbar DRG sections per animal).
Total number of positive cells in each category was cal-
culated for each animal, and the percentages of double
positive neurons with regard to total Nmb+ neurons
(Nmb+; costain+ /total Nmb+) or to total co-staining-
marker-positive neurons (Nmb+; costain+ positive/total
costain+) were calculated. The average and SEM of these
percentages between animals were then calculated.
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